Volume 30 - Issue 7 - October 2022
Column
Chief Medical Editor Message
10/18/2022
With a television series that affected American culture and a net worth of around $1 billion, Emmy Award-winning comedian Jerry Seinfeld can afford to be picky about where to perform.
With a television series that affected American culture and a net worth of around $1 billion, Emmy Award-winning comedian Jerry Seinfeld can afford to be picky about where to perform.
With a television series that...
10/18/2022
The Dermatologist
Department
Board Review
10/18/2022
The contents of these questions are taken from the Galderma Pre-Board Webinar. The Pre-Board Webinar is now an online course. For details, go to https://www.galderma.com/us/preboard-webinar.
The contents of these questions are taken from the Galderma Pre-Board Webinar. The Pre-Board Webinar is now an online course. For details, go to https://www.galderma.com/us/preboard-webinar.
The contents of these questions...
10/18/2022
The Dermatologist
Derm Dx
10/18/2022
A 36-year-old man with no known past medical history presented with light patches on the trunk and extremities that he had for many years.
A 36-year-old man with no known past medical history presented with light patches on the trunk and extremities that he had for many years.
A 36-year-old man with no known...
10/18/2022
The Dermatologist
Conference Highlights
10/18/2022
This year’s fall Dermatology Week delivered education for today’s providers in a fully virtual event.
This year’s fall Dermatology Week delivered education for today’s providers in a fully virtual event.
This year’s fall Dermatology...
10/18/2022
The Dermatologist
Feature
Clinical Insights
10/18/2022
Dupilumab is now FDA approved for pediatric patients aged 6 months to 5 years with moderate to severe disease.
Dupilumab is now FDA approved for pediatric patients aged 6 months to 5 years with moderate to severe disease.
Dupilumab is now FDA approved...
10/18/2022
The Dermatologist
NRS Approved Features
10/18/2022
Persistent erythema is the most common and bothersome sign of rosacea, according to respondents. This highly visible phenotype may lead to serious invisible burdens.
Persistent erythema is the most common and bothersome sign of rosacea, according to respondents. This highly visible phenotype may lead to serious invisible burdens.
Persistent erythema is the most...
10/18/2022
The Dermatologist
NEA Approved Features
10/18/2022
The National Eczema Association and the Pediatric Dermatology Research Alliance have partnered to create Eczema Counts as a shared platform to build knowledge among patients, caregivers, researchers, and clinicians.
The National Eczema Association and the Pediatric Dermatology Research Alliance have partnered to create Eczema Counts as a shared platform to build knowledge among patients, caregivers, researchers, and clinicians.
The National Eczema Association...
10/18/2022
The Dermatologist
